Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
Asset disposition
Acq. announced
Director departure
Appointed director
|
|
MEDICINES CO (MDCO)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2020 |
SC 13G/A
| Boxer Capital, LLC reports a 1.2% stake in THE MEDICINES COMPANY |
| 02/12/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2020 |
SC 13G/A
| VANGUARD SPECIALIZED FUNDS reports a 0% stake in Medicines Co |
| 02/10/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/28/2020 |
SC 13G/A
| Iridian Asset Management reports a 0% stake in The Medicines Company |
| 01/16/2020 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)]: |
| 01/10/2020 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 01/10/2020 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 01/10/2020 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 01/07/2020 |
SC 13D/A
| Sarissa Capital Management LP reports a 0% stake in The Medicines Company |
| 01/07/2020 |
SC 13G/A
| WESTFIELD CAPITAL MANAGEMENT CO LP reports a 1.7% stake in The Medicines Company |
| 01/06/2020 |
4
| Wijngaard Peter (Chief Development Officer) has filed a Form 4 on MEDICINES CO /DE|
Txns:
| Disposed/sold 107,546 shares
@ $0
Disposed/sold 10,000 options
@ $15.94, valued at
$159.4k
Disposed/sold 17,500 options
@ $22.04, valued at
$385.7k
Disposed/sold 40,995 options
@ $31.49, valued at
$1.3M
Disposed/sold 23,639 options
@ $30.55, valued at
$722.2k
Disposed/sold 7,143 options
@ $28.77, valued at
$205.5k
Disposed/sold 30,000 options
@ $28.77, valued at
$863.1k
Disposed/sold 42,539 options
@ $33.04, valued at
$1.4M
Disposed/sold 30,000 options
@ $29.01, valued at
$870.3k
|
|
| 01/06/2020 |
4
| Visioli Christopher (CFO) has filed a Form 4 on MEDICINES CO /DE|
Txns:
| Disposed/sold 68,843 shares
@ $0
Disposed/sold 30,000 options
@ $29.01, valued at
$870.3k
Disposed/sold 24,000 options
@ $29.01, valued at
$696.2k
|
|
| 01/06/2020 |
4
| Timney Mark (CEO) has filed a Form 4 on MEDICINES CO /DE|
Txns:
| Disposed/sold 185,415 shares
@ $0
Disposed/sold 45,000 options
@ $20.79, valued at
$935.6k
Disposed/sold 82,500 options
@ $20.79, valued at
$1.7M
Disposed/sold 110,000 options
@ $20.79, valued at
$2.3M
Disposed/sold 220,000 options
@ $20.79, valued at
$4.6M
|
|
| 01/06/2020 |
4
| Schlesinger Sarah J. (Director) has filed a Form 4 on MEDICINES CO /DE|
Txns:
| Disposed/sold 7,429 shares
@ $0
Disposed/sold 26,383 options
@ $29.83, valued at
$787k
Disposed/sold 9,141 options
@ $33.86, valued at
$309.5k
Disposed/sold 8,410 options
@ $34.81, valued at
$292.8k
|
|
| 01/06/2020 |
4
| Rodin Stephen M (EVP and General Counsel) has filed a Form 4 on MEDICINES CO /DE|
Txns:
| Disposed/sold 84,782 shares
@ $0
Disposed/sold 18,000 options
@ $29.01, valued at
$522.2k
Disposed/sold 24,000 options
@ $29.01, valued at
$696.2k
Disposed/sold 48,000 options
@ $29.01, valued at
$1.4M
Disposed/sold 40,000 options
@ $25.41, valued at
$1M
|
|
| 01/06/2020 |
4
| Panayiotopoulos Paris (Director) has filed a Form 4 on MEDICINES CO /DE|
Txns:
| Disposed/sold 13,881 shares
@ $0
Disposed/sold 16,559 options
@ $51.02, valued at
$844.8k
Disposed/sold 8,577 options
@ $39.39, valued at
$337.8k
Disposed/sold 9,141 options
@ $33.86, valued at
$309.5k
Disposed/sold 8,410 options
@ $34.81, valued at
$292.8k
|
|
| 01/06/2020 |
4
| MEANWELL CLIVE (Chief Innovation Officer) has filed a Form 4 on MEDICINES CO /DE|
Txns:
| Disposed/sold 480,340 shares
@ $0
Disposed/sold 120,000 options
@ $30.55, valued at
$3.7M
Disposed/sold 234,375 options
@ $28.77, valued at
$6.7M
Disposed/sold 297,776 options
@ $33.04, valued at
$9.8M
Disposed/sold 210,793 options
@ $52.7, valued at
$11.1M
Disposed/sold 87,750 options
@ $29.01, valued at
$2.5M
Disposed/sold 117,000 options
@ $29.01, valued at
$3.4M
Disposed/sold 234,000 options
@ $29.01, valued at
$6.8M
Disposed/sold 95,000 options
@ $25.41, valued at
$2.4M
|
|
| 01/06/2020 |
4
| Kelly John C. (Director) has filed a Form 4 on MEDICINES CO /DE|
Txns:
| Disposed/sold 32,148 shares
@ $0
Gifted 25,000 options
@ $16, valued at
$400k
Gifted 25,000 options
@ $16, valued at
$400k
Gifted 13,259 options
@ $18.18, valued at
$241k
Gifted 13,259 options
@ $18.18, valued at
$241k
Gifted 12,039 options
@ $21.14, valued at
$254.5k
Gifted 12,039 options
@ $21.14, valued at
$254.5k
Gifted 9,763 options
@ $33.13, valued at
$323.4k
Gifted 9,763 options
@ $33.13, valued at
$323.4k
Gifted 10,016 options
@ $27.78, valued at
$278.2k
Gifted 10,016 options
@ $27.78, valued at
$278.2k
|
|
| 01/06/2020 |
4
| Germano Geno J (Director) has filed a Form 4 on MEDICINES CO /DE|
Txns:
| Disposed/sold 7,429 shares
@ $0
Disposed/sold 27,243 options
@ $30.9, valued at
$841.8k
Disposed/sold 9,141 options
@ $33.86, valued at
$309.5k
Disposed/sold 8,410 options
@ $34.81, valued at
$292.8k
|
|
| 01/06/2020 |
4
| DENNER ALEXANDER J (Director) has filed a Form 4 on MEDICINES CO /DE|
Txns:
| Disposed/sold 85,813 shares
@ $0
Disposed/sold 4,202,000 shares
@ $0
Disposed/sold 27,230 options
@ $32.86, valued at
$894.8k
Disposed/sold 9,700 options
@ $37.22, valued at
$361k
Disposed/sold 8,577 options
@ $39.39, valued at
$337.8k
Disposed/sold 9,141 options
@ $33.86, valued at
$309.5k
Disposed/sold 13,410 options
@ $34.81, valued at
$466.8k
|
|
| 01/06/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 01/06/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 01/06/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 01/06/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 01/06/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 01/06/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 01/06/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 01/06/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 01/06/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 01/06/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 01/06/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 01/06/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 01/06/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
|
|
|